Recently, an authoritative and representative China's pharmaceutical industry annual award "Xin Rui" was announced. Shandong Lukang Pharmaceutical Co.,ltd won the “Jin Xi” Award of representing actively taking social responsibility and it’s product--Cefuroxime Axetil dry suspensions, won the “Pu Yu” Award of representing excellent quality.
Cefuroxime Axetil dry suspensions is the second-generation cephalosporin. It is the first choice for the treatment of children respiratory, skin and soft tissue infection. It has higher safety, less toxicity and adverse reactions.